Ro launches GLP-1 insurance coverage checker
Zoom iconArrows pointing outwards Direct-to-consumer healthcare startup Ro on Tuesday launched a new, free tool to help patients determine whether…
Biotechnology and pharmaceuticals
Eli Lilly (LLY) Q2 2024 Earnings
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, September 17, 2020. Mike…
What Wall Street is watching
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…
CVS Health (CVS) Q2 2024 Earnings
The CVS Pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, Feb.…
Pharmaceutical companies negotiate new prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris…
FDA says Eli Lilly's Zepbound and Mounjaro are available after shortage
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City, Dec. 11, 2023. Brendan McDermid…
Eli Lilly's Zepbound weight-loss drug cuts heart failure risks, study finds
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
Biogen (BIIB) Q2 2024 Results
Biogen The company on Thursday reported second-quarter earnings and revenue, which beat estimates and raised its full-year guidance as the…
Moderna (MRNA) earnings in the second quarter of 2024
Modern On Thursday, it reported second-quarter revenue that beat expectations but cut its full-year sales outlook, citing lower expected sales…
GLP-1s are being tested for uses beyond weight loss and diabetes
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…